Background: Although primary cancer of the fallopian tubes is a relatively rare type of tumor in female reproductive organs, its mortality is quite high. It is important to identify molecular and biological markers of this malignancy that determine its specific phenotype. Methods: The study was carried out on samples received from 71 female patients with primary cancer of the fallopian tubes. The main molecular and biological properties, including hormone status (estrogen receptor [ER], progesterone receptor [PR]), human epidermal growth factor receptor (HER2)/neu expression, proliferative potential (Ki-67), apoptosis (p53, Bcl-2), and pro-angiogenic (vascular endothelial growth factor) quality of serous tumors were studied in comparison wi...
Serous type Fallopian tube carcinoma (FTC) and ovarian carcinoma (OVCA) are gynaecological malignanc...
Background: Primary fallopian tube carcinoma (PFTC) is a rare gynecological malignancy though its pr...
Background: The incidence of cancer is increasing day by day. Ovarian cancer ranks as the fifth lead...
Background: Although primary cancer of the fallopian tubes is a relatively rare type of tumor in fem...
Primary cancer of the fallopian tubes (PCFT) has the lowest incidence of tumors of the female reprod...
Abstract: The rare occurrence of the fallopian tubes cancer allows to assert that the experience of ...
Primary fallopian tube cancer (PFTC) is a rare and aggressive gynecologic malignancyand it accounts ...
INTRODUCTION: Serous carcinomas are the most frequent histologic type of ovarian and peritoneal canc...
Primary fallopian tube carcinoma is a rare gynecological cancer. Loco regionally advanced disease is...
Context: Ovarian tumors are the seventh most common cause of death by cancer among women. Serous car...
Background & Objective: The object of this research was to study the qualitative composition of the ...
Fallopian tube carcinoma (FTC) is considered a rare malignancy, but recent evidence shows that its i...
Epithelial ovarian cancer is the second most common gynaecological cancer, but has the highest fatal...
AbstractAlthough controversial, recent studies suggest that serous ovarian carcinomas may arise from...
Primary Fallopian tube carcinoma (PFTC) is one of the rarest malignant tumours of the female genital...
Serous type Fallopian tube carcinoma (FTC) and ovarian carcinoma (OVCA) are gynaecological malignanc...
Background: Primary fallopian tube carcinoma (PFTC) is a rare gynecological malignancy though its pr...
Background: The incidence of cancer is increasing day by day. Ovarian cancer ranks as the fifth lead...
Background: Although primary cancer of the fallopian tubes is a relatively rare type of tumor in fem...
Primary cancer of the fallopian tubes (PCFT) has the lowest incidence of tumors of the female reprod...
Abstract: The rare occurrence of the fallopian tubes cancer allows to assert that the experience of ...
Primary fallopian tube cancer (PFTC) is a rare and aggressive gynecologic malignancyand it accounts ...
INTRODUCTION: Serous carcinomas are the most frequent histologic type of ovarian and peritoneal canc...
Primary fallopian tube carcinoma is a rare gynecological cancer. Loco regionally advanced disease is...
Context: Ovarian tumors are the seventh most common cause of death by cancer among women. Serous car...
Background & Objective: The object of this research was to study the qualitative composition of the ...
Fallopian tube carcinoma (FTC) is considered a rare malignancy, but recent evidence shows that its i...
Epithelial ovarian cancer is the second most common gynaecological cancer, but has the highest fatal...
AbstractAlthough controversial, recent studies suggest that serous ovarian carcinomas may arise from...
Primary Fallopian tube carcinoma (PFTC) is one of the rarest malignant tumours of the female genital...
Serous type Fallopian tube carcinoma (FTC) and ovarian carcinoma (OVCA) are gynaecological malignanc...
Background: Primary fallopian tube carcinoma (PFTC) is a rare gynecological malignancy though its pr...
Background: The incidence of cancer is increasing day by day. Ovarian cancer ranks as the fifth lead...